×
Sotrovimab - sotrovimab injection, solution, concentrate-GlaxoSmithKline LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa5cca2e-4351-4f81-b0e5-3303ac0b2474

Jul 9th, 2021 - SPL UNCLASSIFIED SECTION The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product sotrovimab for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing...

Novavax covid-19 vaccine, adjuvanted - nvx-cov2373 injection, suspension-Novavax Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b237fbc-d58a-4ca0-a56b-f9425d14dab5

Apr 28th, 2021 - PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 80631-100-01 NOVAVAX COVID-19 Vaccine, Adjuvanted Suspension for intramuscular injection Multi-dose vial (10 doses of 0.5 mL) Record date/time of first use: Date: Time: Manufactured for: Novavax, Inc., Gaithersburg, MD 20878 vial label PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 80631-100-10 10 Multi-Dose Vials (each vial contains 10 doses of 0.5 mL) NO...

Propofol lipuro - propofol lipuro injection, emulsion-B. Braun Medical Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e993c6cc-63c6-42c9-b509-52ceb16fc9b5

Mar 12th, 2021 - HEALTH CARE PROVIDER LETTER SECTION EMERGENCY USE AUTHORIZATION (EUA) OF PROPOFOL-LIPURO 1% INJECTABLE EMULSION FOR INFUSION The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, Propofol-Lipuro 1% injectable emulsion for infusion in 100 mL to maintain sedation via continuous infusion in patients greate...

Lilly's bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19
https://investor.lilly.com/news-releases/news-release-details/lillys-bamlanivimab-and-etesevimab-together-reduced
Eli Lilly and Company

Mar 10th, 2021 - INDIANAPOLIS, March 10, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data from the randomized, double-blind, placebo-controlled BLAZE-1 Phase 3 study, demonstrating bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together significantly reduced COVID-19 related hospitalizations and deaths ("events") in high-risk patients recently diagnosed with CO...

Regen-cov - casirivimab and imdevimab kit-Regeneron Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5bf7a31-7e17-4a94-805c-d231ea458fb0

Mar 10th, 2021 - SPL UNCLASSIFIED SECTION FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF REGEN-COV™ (casirivimab with imdevimab) SPL UNCLASSIFIED SECTION The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, REGEN-COV (casirivimab with imdevimab to be administered together), for the treatmen...

Etesevimab - etesevimab injection, solution-Eli Lilly and Company
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aacdd8a7-18b7-43c6-b866-14aa491a0c15

Feb 9th, 2021 - SPL UNCLASSIFIED SECTION The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved products bamlanivimab and etesevimab administered together for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive re...

Janssen covid-19 vaccine - ad26.cov2.s injection, suspension-Janssen Products, LP
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14a822ff-f353-49f9-a7f2-21424b201e3b

Feb 1st, 2021 - PACKAGE LABEL.PRINCIPAL DISPLAY PANEL AW_177786 For use under Emergency Use Authorization Janssen COVID-19 Vaccine 5 doses of 0.5 mL Intramuscular Injection No Preservative For EXP: www.vaxcheck.jnj After first use, hold at 2°C to 8°C (36°F to 46°F). Discard after 6 hours. Record date and time of first use: LOT Principal Display Panel - 2.5 mL Vial Label PACKAGE LABEL.PRINCIPAL DISPLAY PANEL ...

Pfizer-biontech covid-19 vaccine - bnt162b2 injection, suspension-Pfizer Manufacturing Belgium NV
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=908ecbe7-2f1b-42dd-94bf-f917ec3c5af8

Jan 27th, 2021 - Pfizer-BioNTech COVID-19 Vaccine is authorized for use under an Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years of age and older.

Moderna covid-19 vaccine - cx-024414 injection, suspension-Moderna US, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0651c7a-2fe2-459d-a766-0d59e919f058

Jan 11th, 2021 - SPL UNCLASSIFIED SECTION The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product, MODERNA COVID-19 VACCINE, for active immunization to prevent COVID-19 in individuals 18 years of age and older. SPL UNCLASSIFIED SECTION Vaccination providers enrolled in the federal COVID-19 Vaccination Program must report...

Extreme sanitizer - hand sanitizer liquid-Earth Wind Fire L.L.C. / Extreme Sanitizer®
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a5926392-d9ff-69a2-e053-2995a90a9c8f

Dec 28th, 2020 - PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Extreme Sanitizer® Kills 99.99% of Germs in 15 Seconds Effective Hand Sanitizer Advanced Formula KILLS CORONAVIRUS IN 15 SECONDS Hypoallergenic and ALCOHOL-FREE Drug Facts Active Ingredient:Alkylbenzyldimethylammonium Chloride (Quaternary Ammonium) 0.13%…Antiseptic Use: For hand sanitation. No water wash. WARNING: Avoid eye contact, flush with water. Keep o...

Astrazeneca covid-19 vaccine - azd1222 injection, suspension-AstraZeneca Pharmaceuticals LP
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f0531bd-4e0a-4246-8c1e-11fc5658e950

Dec 22nd, 2020 - PACKAGE LABEL.PRINCIPAL DISPLAY PANEL AstraZeneca COVID-19 Vaccine NDC 0310-1222-10 For use under Emergency Use Authorization Suspension for Intramuscular Injection After first use, discard after: 6 hours at 20°-25°C (68°-77°F), or 48 hours at 2°-8°C (36°-46°F) For Exp Date: see www.azcovid-19.com Multi-dose vial (10 doses of 0.5 mL) vial_label_5ml PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 03...

Veklury - remdesivir injection-Gilead Sciences, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98b7e6bf-2668-4a61-a874-194eb674b15c

Dec 21st, 2020 - HEALTH CARE PROVIDER LETTER SECTION IMPORTANT PRESCRIBING INFORMATION Subject: Updated Emergency Use Authorization (EUA) for hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg with suspected or laboratory-confirmed COVID-19 and variations in carton and vial labeling of VEKLURY ® (remdesivir) De...

Veklury - remdesivir injection-Gilead Sciences, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0978fa8-53ff-4ca2-82a7-567fd3e958ca

Dec 18th, 2020 - VEKLURY is indicated for adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of coronavirus disease 2019 (COVID-19) requiring hospitalization. VEKLURY should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care [see Clinical Studies (14)] .

Bamlanivimab - bamlanivimab injection, solution-Eli Lilly and Company
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c7e9d8a6-e8c2-4681-9362-51d5bdbae00d

Dec 11th, 2020 - SPL UNCLASSIFIED SECTION The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product bamlanivimab for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testi...

Aktive multi purpose antibacterial - hypochlorous acid liquid-Hall Global LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4e1c0d6-4a38-2fe9-e053-2995a90a12af

Nov 24th, 2020 - Decreases bacteria on skin.Sanitizing/Antimicrobial Agent Solution is on the EPA N-List N-Product with Emerging Viral Pathogens and Human Coronavirus claims for use against SARS CoV-2

Antigen component - cov-2 pres dtm antigen injection, emulsion-Sanofi Pasteur Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb83efb8-9233-48bf-979d-0fb7a24456ea

Nov 9th, 2020 - SPL UNCLASSIFIED SECTION Health Care Professional and Patient Fact Sheets are not available at this time. PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 49281-618-78 Vial 1 of 2 ANTIGEN COMPONENT for Sanofi Pasteur COVID-19 Vaccine, Adjuvanted After mixing, emulsion for intramuscular injection For use under Emergency Use Authorization. NOT TO BE USED ALONE. Add 1 vial of AS03 Adjuvant Component to...

Resp homo - human coronavirus (rna) liquid-Deseret Biologicals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f437b94-ce56-41fe-9157-4f19c5dfe5cb

Sep 24th, 2020 - For the temporary relief of symptoms such as runny nose, cough, and fever.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Act kit (accelerated covid-19 test kit) - lidocaine and prilocaine, isopropyl alcohol kit-Asclemed USA, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b20d711-8818-4290-8113-2c9e3f20b789

Sep 22nd, 2020 - Lidocaine and prilocaine cream (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on: - normal intact skin for local analgesia.     - genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lidocaine and prilocaine cream is not recommended in any clinical situation when penetration or migration ...